Tagotongan, Emma D.
HRN: 00-07-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2025
CEFUROXIME 750MG (VIAL)
07/12/2025
07/12/2025
IVT
1.5gm
ON CALL TO OR THEN Q 8
LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes